Cited by 64RNA Research and SplicingAlzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research

SRp54 (SFRS11), a Regulator for tau Exon 10 Alternative Splicing Identified by an Expression Cloning Strategy

Open access
Wu, Jane Y., Kar, Amar, Kuo, David, Yu, Bing, Havlioglu, Necat·2006·Molecular and Cellular Biology

Abstract

The tau gene encodes a microtubule-associated protein that is critical for neuronal survival and function. Splicing defects in the human tau gene lead to frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), an autosomal dominant neurodegenerative disorder. Genetic mutations associated with FTDP-17 often affect tau exon 10 alternative splicing. To investigate mechanisms regulating tau exon 10 alternative splicing, we have developed a green fluorescent protein reporter for tau exon 10 skipping and an expression cloning strategy to identify splicing regulators. A role for SRp54 (also named SFRS11) as a tau exon 10 splicing repressor has been uncovered using this strategy. The overexpression of SRp54 suppresses tau exon 10 inclusion. RNA interference-mediated knock-down of SRp54 increases exon 10 inclusion. SRp54 interacts with a purine-rich element in exon 10 and antagonizes Tra2beta, an SR-domain-containing protein that enhances exon 10 inclusion. Deletion of this exonic element eliminates the activity of SRp54 in suppressing exon 10 inclusion. Our data support a role of SRp54 in regulating tau exon 10 splicing. These experiments also establish a generally useful approach for identifying trans-acting regulators of alternative splicing by expression cloning.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mcb.00739-06

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [6]6. Chaudhary, N., C. McMahon, and G. Blobel. 1991. Primary structure of a human arginine-rich nuclear protein that colocalizes with spliceosome components. Proc. Natl. Acad. Sci. USA 88: 8189-8193.
  2. [23]23. Jiang, Z. H., W. J. Zhang, Y. Rao, and J. Y. Wu. 1998. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. Proc. Natl. Acad. Sci. USA 95: 9155-9160.
  3. [45]45. Wu, J. Y., L. Yuan, and N. Havlioglu. 2004. Alternatively spliced genes, p. 125-177. In R. A. Meyers (ed.), Encyclopedia of molecular cell biology and molecular medicine, 2nd ed., vol. 1. Wiley-VCH, Weinheim, Germany.

Cited by

Sorted by citations

Authors
Wu, J. Y., Kar, A., Kuo, D., Yu, B., & Havlioglu, N.
Affiliations
  • Northwestern University (US)
  • Saint Louis University (US)
Venue
Molecular and Cellular Biology
Published
2006-09-01
Volume
26
Issue
18
Pages
6739-6747
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2107411080
Cited by
64
References
3
Citations by year
2026: 1 · 2023: 5 · 2022: 1 · 2021: 5 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 4 · 2013: 4 · 2012: 4
FWCI
2.72
Type
journal article
Language
en
Open access
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Muscular Dystrophy Association
  • National Institutes of Health
  • National Institute on Aging (AG 17518, R01AG017518)
  • National Eye Institute (R01EY014576)
  • National Institute of General Medical Sciences (GM 07967)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
SRP54, alternative splicing, splicing repressor, FTDP-17, frontotemporal dementia with parkinsonism linked to chromosome 17, Tra2β, SR proteins, expression cloning
MeSH terms
Serine-Arginine Splicing Factors, Binding, Competitive, Brain, Cloning, Molecular, Enhancer Elements, Genetic, Exons, Fetus, Humans, Nuclear Proteins, Protein Binding, Purines, RNA, Messenger, Transcriptional Activation, Down-Regulation, Gene Library, Gene Expression, tau Proteins, Sequence Deletion, Alternative Splicing, Genes, Reporter, RNA Interference, Green Fluorescent Proteins, Membrane Cofactor Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review